Show simple item record

dc.creatorCengiz, Mahir
dc.creatorBorku Uysal, Betul
dc.creatorIkitimur, Hande
dc.creatorOzcan, Erkan
dc.creatorSami Islamoglu, Mehmet
dc.creatorAktepe, Emre
dc.creatorYavuzer, Hakan
dc.creatorYavuzer, Serap
dc.date.accessioned2020-09-22T15:48:47Z
dc.date.available2020-09-22T15:48:47Z
dc.date.created2020
dc.identifier.issn2352-9393spa
dc.identifier.otherhttps://doi.org/10.1016/j.yclnex.2020.07.003spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/13564
dc.description.abstractObjectives: The aim of this study is to investigate the effect of oral L-Glutamine supplementation on hospitalization time, need for intensive care unit and Coronavirus Disease-19 (Covid-19) mortality. Methods: The study included 30 Covid-19 patients using L-Glutamine and 30 Covid-19 patients who did not use L-Glutamine with similar age, gender and clinical status. Diagnostic tests, laboratory examinations, clinical findings and computed thorax tomography imaging of the patients were evaluated. Results: Hospitalization time was 10.4 ± 1.9 days in Covid-19 without L-Glutamine group and 8.9 ± 1.8 days in Covid-19 with LGlutamine group (p ¼ 0.005). In Covid-19 without the L-Glutamine group, four patients require the ICU though no one in the other group required that (p ¼ 0.038). Only one mortality was observed in Covid-19 without the L-Glutamine group (p ¼ 0.999). Conclusions: Nutritional supplements such as L-Glutamine boost immune system especially by inhibition of inflammatory responses. Our results suggest adding enteral L-glutamine to the normal nutrition in the early period of Covid-19 infection may lead to a shortened hospital stay and lead to less need for ICU. Largerscale studies are needed to evaluate the effect of adding enteral LGlutamine to the currently used treatments in the infectious diseases especially like Covid-19.spa
dc.format.extent8 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherClinical Nutrition Experimentalspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCovid-19spa
dc.subjectSARS Cov-2spa
dc.subjectPneumoniaspa
dc.subjectL-Glutaminespa
dc.subjectNutritionspa
dc.titleEffect of oral L-Glutamine supplementation on Covid-19 treatmentspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.yclnex.2020.07.003spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record